Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Tan Sheet

Executive Summary

HELENE CURTIS' DEGREE "BODY HEAT ACTIVATED" CLAIMS SUBSTANTIATED by the company, the National Advertising Division (NAD) of the Council of Better Business Bureaus stated in a Nov. 24 Case Report. Following review of two clinical studies provided by Helene Curtis, the watchdog organization concluded that "there was sufficient evidence in the materials submitted by the advertiser to support its claim" that the antiperspirant and fragrance actions of Degree antiperspirant/deodorant are triggered by an increase in body temperature. Helene Curtis launched Degree in January 1990. NAD's review focused on print advertising for Degree, which came to the group's attention through its routine monitoring program. NAD initiated the inquiry with a Sept. 9 letter to Helene Curtis. The ad agency of record for Degree is Saatchi & Saatchi, New York. NAD also questioned the exclusivity of Helene Curtis' claim that "only Degree has the body-heat activated formula that releases extra protection when you need it most." Helene Curtis has agreed to remove the word "only" from the claim. The firm informed NAD that, while it believes "Degree's formula to be unique," it will voluntarily modify its claim "in response to the recent entry of a product, which has a different formula but uses the same method of delivery," NAD said. Commenting on NAD's conclusions, Helene Curtis stated that the firm "is pleased that the NAD has determined that our claims for Degree antiperspirant/deodorant have been substantiated."

You may also be interested in...

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts